Adeptus Health (ADPT): MedPAC Fires A Warning Shot - Jefferies
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Jefferies analyst, Brian Tanquilut, reiterated his Hold rating on shares of Adeptus Health (NYSE: ADPT) after comments made at a recent Medicare Payment Advisory Commission meeting highlighted upcoming regulatory and reimbursement scrutiny of the freestanding ER space at a time when the entry of a new administration is expected to usher in new healthcare legislation that could include Medicare reform.
Stand-alone ERs are on MedPAC's radar, and not in a good way. The influential Medicare Payment Advisory Commission (MedPAC, which provides Congress advice on Medicare matters) held a discussion regarding the proliferation of free-standing ERs at its November meeting, and based on commissioners' comments, it is apparent that the panel is skeptical whether current patient acuity levels and services provided by FSERs justify reimbursement rates that are equivalent to hospital-based ERs. Several members expressed a view that FSERs bear a closer resemblance to Urgent Care Clinics than traditional EDs, and thus should be reimbursed based on the Physician Fee Schedule with no facility fees.
No change to the price target of $13.
Shares of Adeptus Health closed at $10.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Cuts Price Target on Workday (WDAY) to $71 Following 3Q
- JPMorgan Raises Rating on CBOE Holdings (CBOE) to 'Overweight'; Analyst Thinks Bats Technology Will Drive Greater Trading Activity
- Jefferies Cuts Price Target on Dollar General (DG) Following 3Q
Create E-mail Alert Related CategoriesAnalyst Comments
Related EntitiesJefferies & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!